Hepatitis Flashcards

1
Q

How do you treat an acute HBV infection in an adult?

A

No treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How do you treat a Neonate of a HBsAg+ mother?

A

Vaccinate!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How do you treat a chronic HBV patient?

A
  • IFN/pegylated IFN (limited efficacy - knock viral load down but won’t clear it)
  • Lamivudine (DDNRTI)
  • Adefovir - acyclic analogue of dATP
  • Entecavir - guanine analogue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Does tenofovir clear the HBV?

A

No, it just knocks the viral load down

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Which hepatitis requires coinfection with B?

A

Hepatitis D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the structure of HDV

A

Circular ssRNA encoding delta antigen

  • Packaged with HBV S antigen (HBVsAg)
  • HDV with HBV increases severity of hepatitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Does the vaccine for HBV also cover for HDV?

A

yes, because it requires coinfection!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Is there a DNA component to the delta antigen? Does it need a RNA dependent RNA polymerase?

A

No DNA component

Requires Pol II, does not encode its own polymerase - fools pol II to take an RNA template instead of a DNA template

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

True or false - when you clear hepB you clear hepD

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

If you have chronic HBV and then get an HDV super infection, can you clear HDV?

A

No, HDV becomes chronic alongside HBV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

When was HCV discovered?

A

1989

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

General characteristics of HCV

A
  • Hepacivirus (Flaviviridae)
  • Genotypes 1-7, multiple subtypes
  • Parenteral transmission
  • Does not replicate in mosquito - not arborovirus
  • Acute infections are subclinical
  • 50-80% of acute infections become chronic infections
  • No Vaccine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Treatment options for HCV

A
  • IFN and Ribavirin
  • Peg-IFN + Rb
  • Peg-IFN + Rb + HCV protease inhibitors
  • All-oral DAAs (direct acting antivirals) - target NS3-4A protease, NS5A, and NS5B RdRP inhibitors

1 pill a day for 12 wks with DAAs = cure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Most common cause of spread of HCV in US

A

IV drug abuse / Inappropriate use of injection drugs in healthcare settings

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Replication of HCV

A

+ strand RNA –> - strand synthesis –> + strand synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Mutation rate of HCV

A

1*10^4 errors per nt (1 error per 10kb)
40 RCs per hepatocyte
10^12 HCV virions per day per person

17
Q

Which genotype is the most common in the US?

A

Genotype 1

18
Q

How long is the HCV incubation period?

A

6-7 weeks

19
Q

What is the most common reason for liver transplants in the US?

A

HCV associated liver failure

20
Q

What was a common (but not good) outcome of treatment with peg-IFN and Ribavirin

A

ETR - End of Treatment Response

  • they looked like it went away for the duration of treatment and then relapsed as soon as they came off of treatment
21
Q

Genetic variation in ___ predicts HCV treatment-induced viral clearance

A

IL28B (IFN-1) variation

22
Q

Telaprevir and Boceprevir are what class of DAAs

A

They are NS3/4A Protease inhibitors

23
Q

Patient has elevated liver enzymes in serum and elevated serum bilirubin… what do they have?

A

Hepatitis

24
Q

Patient has anti-HAV IgM… Dx?

A

Recent infection

25
Q

Patient has Anti-HAV IgG … Dx?

A

Past infection or vaccine (lifelong immunity)